September 2026

207 Articles

Beyond the Guidelines

Sex and gender in the era of personalized medicine: beyond one-size-fits-all

23 July 2026
Author(s): Maria Rosa Ballester-Verneda

Medicine has traditionally relied on standardized diagnostic and therapeutic protocols perceived as universal and neutral. However, this presumed neutrality reflects a structural bias in the... more

Beyond the guidelines: Preventing heatwave-related admissions and decompensations through thermopharmacological frailty

15 July 2026
Author(s): Francisco Epelde

Heatwaves are becoming more frequent, intense, and prolonged in Europe, creating a predictable clinical stressor for multimorbid patients and increasing pressure on Internal Medicine services.... more

Clinical Insights

Carbapenem-resistant Acinetobacter baumannii pneumonia: Treatment challenges

19 August 2026
Author(s): Demosthenes Makris, Jordi Rello

Carbapenem-resistant Acinetobacter baumannii (A. baumannii) (CRAB) is a cause of ventilator-associated pneumonia (VAP) that can be devastating. Suggested approaches are based on literature review,... more

Multiparametric and multi-organ ultrasound assessment of adiposity for cardiovascular risk stratification

26 May 2026
Author(s): Andrea Boccatonda, Arrigo Francesco Giuseppe Cicero

For decades, clinical practice relied on deceptively simple anthropometric measures—most notably body mass index (BMI), waist circumference, waist-to-hip ratio, and waist-to-height ratio (WHtR)—to... more

Commentary

Hyponatremia among frail and elderly: still poorly managed, but at what cost?

24 August 2026
Author(s): Buster Mannheimer, Henrik Falhammar, Jakob Skov

Hyponatremia affects between 10% and 30% of hospitalized patients, making it by far the most common electrolyte disorder in clinical practice. Symptoms vary but often include confusion, nausea, and... more

Subclinical hypotension in acute decompensated heart failure: a warning signal, not a therapeutic barrier

24 August 2026
Author(s): Luis M. Pérez-Belmonte, Ricardo Gómez-Huelgas

Acute decompensated heart failure (ADHF) is characterized by marked clinical and hemodynamic heterogeneity, making the interpretation of blood pressure (BP) particularly challenging[1]. Low BP is... more

Fluid balance in critical illness: From arbitrary thresholds to outcome-linked stewardship

21 August 2026
Author(s): Carmine Zoccali, Francesca Mallamaci

Fluid therapy remains one of the most common, powerful, and potentially hazardous interventions in intensive care. For decades, clinicians have understood that both under-resuscitation and over-... more

Breaking LDL-cholesterol inertia after myocardial infarction: from discharge prescription to closed-loop care

20 August 2026
Author(s): Pierre-Guillaume Piriou, Philippe Gabriel Steg

Acute myocardial infarction is both an emergency and the beginning of a prolonged period of exceptionally high recurrent cardiovascular risk. Few components of secondary prevention are supported by... more

A step toward precision screening for occult cancer after venous thromboembolism

19 August 2026
Author(s): M Di Nisio, N van Es

Venous thromboembolism (VTE) has long been recognized as one of the earliest clinical manifestations of an underlying malignancy. More than 160 years after Trousseau first recognized the association... more

Subclinical atrial fibrillation in patients treated with Bruton’s tyrosine kinase inhibitors: ‘Much ado about nothing or phantom menace’

18 August 2026
Author(s): Andrés J. Muñoz Martín, Eduardo Zatarain-Nicolás, Sara Pérez Ramírez

Bruton's tyrosine kinase inhibitors (BTKis) have reshaped the therapeutic landscape of B cell malignancies, significantly improving survival outcomes [1]. However, cardiovascular side effects,... more

Hyperuricemia and prevention of cardiometabolic disease: Unexplored is not unexpected

1 August 2026
Author(s): Claudio Borghi, Bentivenga Crescenzio

For decades, the management of hyperuricemia has been largely driven by the occurrence of gout. Outside the context of crystal-induced disease, asymptomatic hyperuricemia has traditionally been... more

Inflammatory disbalance marks high-risk multi-morbid patients with COPD

31 July 2026
Author(s): Lies Lahousse, Michael D. Weiden

Lung cancer, neuropsychiatric and musculoskeletal comorbidities are major drivers of transitioning from a never to frequent exacerbator phenotype in COPD and cardiovascular comorbidities... more

Broad-minded or highly specialised: Which physician provides the best care for acutely Ill medical patients?

14 July 2026
Author(s): Marcel Levi

Driven by major advances in molecular genetics, cell biology, physics, and data science, medicine is evolving at an unprecedented pace. Across virtually all areas of internal medicine, therapeutic... more

Early vasopressin in septic shock: Which evidence should we trust?

11 July 2026
Author(s): Giovanna Guiotto

Choosing the best treatment for septic shock, which remains one of the leading causes of death in the world, is still one of the most difficult challenges facing emergency physicians, despite timely... more

Positive urine cultures before neutropenia: Interpreting the organism through the host

7 July 2026
Author(s): Antonios Katsounas, Jordi Rello

In this issue of the European Journal of Internal Medicine, Tolosa-Ridao and colleagues address a deceptively simple but clinically consequential question: should asymptomatic bacteriuria detected... more

Corrigendum

Corrigendum to “Identifying distinct clinical phenotypes and outcomes in adult-onset IgA vasculitis using unsupervised clustering analysis” [European Journal of Internal Medicine 147 (2026) 106742]

15 July 2026
Author(s): Valentin Maisons, Antoine Hankard, Alojzija Hočevar, Evangeline Pillebout, Jean-Michel Halimi, Bénédicte Sautenet, Christelle Barbet, Noémie Jourde-Chiche, Alexandre Karras, Jean-François Augusto, Xavier Puéchal, Stanislas Faguer, Christian Lavigne, Kim Baud, Alexis Archambeaud, Hubert de Boysson, Achille Aouba, François Maillot, Benjamin Terrier, Yann Nguyen, Alexandra Audemard-Verger

The authors regret the partial omission of Dr Antoine Hankard’s affiliation details. The correct affiliation information is listed above, and subsequent affiliations have been renumbered accordingly... more

Editorial

P‑values aren’t the problem - 0.05 and our interpretation are. The 7 deadly sins that distort health research

7 August 2026
Author(s): Edward James Watts

Randomness describes non-deterministic events and is measured through probability. A Galton board illustrates this. Each pin represents a 50/50 chance of moving left or right, like repeated coin... more

When the prescribing of medications triggers a diagnostic cascade

19 July 2026
Author(s): Graziano Onder, Jerry H. Gurwitz, Joyce Li, Paula A. Rochon

Prescribing cascades are traditionally defined as a sequence in which an adverse effect of a medication is misinterpreted as a new medical condition, leading to the prescription of additional... more

Would a single centralized ethical review in Europe be feasible for multinational trials in public health emergencies?

28 May 2026
Author(s): Rafael Dal-Ré, Søren Holm

In the development of clinical research guidelines and regulations over the past 60 years, those relating to research ethics have deserved special attention. Among these, all those referring to the... more

Ideas and Opinions

Targeting the kidney-gut axis in chronic kidney disease: From biological insight to therapeutic opportunity

14 July 2026
Author(s): Domenico Bagordo, Giovanni Santacroce, Giorgia Adiutori, Federica Biasi, Maria Vittoria Parola, Antonio Di Sabatino

Chronic kidney disease (CKD) is increasingly recognized as a systemic disorder characterized by complex metabolic, inflammatory, and cardiovascular interactions [1]. Beyond the progressive decline in... more

Why rare uninformative findings appear highly specific

6 July 2026
Author(s): José Nunes de Alencar

Sensitivity and specificity remain the dominant metrics for evaluating diagnostic tests in clinical epidemiology, and the Spin and Snout mnemonic—“specific findings rule disease in, sensitive... more

Disease clearance in immune-mediated gastrointestinal disorders: A new standard or a semantic trap?

17 June 2026
Author(s): Giovanni Santacroce, Marco Vincenzo Lenti, Antonio Lo Bello, Antonio Di Sabatino

Immune-mediated gastrointestinal disorders, including eosinophilic oesophagitis, coeliac disease, and inflammatory bowel disease, are increasingly managed with therapeutic goals that extend beyond... more

Internal Medicine Flashcard

Reverse Fitz-Hugh–Curtis syndrome

21 August 2026
Author(s): Sho Koshikizawa, Kosuke Ishizuka, Shintaro Kosaka

A 40-year-old woman presented with left lower abdominal pain that had begun 2 days earlier and subsequently shifted to the left hypochondrium. The pain was persistent, worsened with deep inspiration... more

Disseminating subcutaneous nodules without systemic symptoms in an elderly man

16 August 2026
Author(s): Mika Watanabe, Chihiro Shiiya, Hiroko Gotoda

A man in his 90 s presented with a 1-month history of more than ten 1–2-cm, elastic-hard, mildly bluish subcutaneous nodules distributed across the chest, abdomen, and thighs, without associated pain... more

When blood doesn’t flow: a 21-year-old man with recurrent arthralgia and muscle soreness

10 August 2026
Author(s): M.A González Fernández, H Calderón Álvarez, I Salguero Rodríguez

A 21-year-old patient presented with intermittent episodes of myalgia, arthralgia, and bone pain in the extremities and spine, triggered by physical exertion and dating back 9 years. The patient had... more

A flower blooming in the Lung

10 August 2026
Author(s): Annarita Botta, Rossella Filippelli, Roberto Parrella

A 63-year-old Italian woman was referred to our outpatient pulmonology clinic with a three-month history of productive cough associated with yellowish, flake-like sputum and profound asthenia. She... more

A Woman with Progressive Skin Ulceration

20 July 2026
Author(s): Kodai Sakiyama, Hiroyuki Yano, Mitsuyo Kinjo

A 62-year-old woman with heavy alcohol use developed difficulty walking and reduced oral intake over two weeks, followed by altered consciousness, disorientation, hallucinations, and watery diarrhea... more

Chronic hyperkeratotic and pustular cutaneous lesions of the hand

23 June 2026
Author(s): Claude Bachmeyer, Philippe Moguelet, Jean-Benoit Monfort

A 49-year-old Algerian woman, was referred for evaluation of cutaneous lesions evolving for four years suggestive of chronic infection. His medical history was relevant for diabetes mellitus... more

Opportunistic infections in a patient with T-cell lymphocytopenia of unclear cause

16 June 2026
Author(s): Sabrina Belhabib, David Boutboul, Claude Bachmeyer

A 57-year-old Moroccan woman with no relevant personal and family history presented with a 2 month history of progressive loss of vision of the left eye. Vital signs were normal. Ophthalmologic... more

The “flame sign” in a young painter with acute neurologic deterioration

15 June 2026
Author(s): Binglin Lai

A 24-year-old man, a painter with two years of occupational exposure to paints and thinners under poorly ventilated conditions (8–10 h daily), presented with a three-month history of headache,... more

Facial swelling with unexpected pelvic hypermetabolism

28 May 2026
Author(s): Margaux Soulard, Tangi Le Coz, Erwan Le Tallec

A 59-year-old man with a history of smoking and adult-onset asthma with recurrent eosinophilia presented with fatigue and weight loss, along with a progressive left facial swelling involving the... more

Invited Review Article

Artificial intelligence in medicine: An ethical and legal review

26 August 2026
Author(s): Sebastian Schleidgen, Orsolya Friedrich

The integration of artificial intelligence (AI) and machine learning (ML) into medical practice marks a transformative shift within healthcare delivery, diagnostics, and treatment paradigms. Although... more

Artificial intelligence in diagnostics and medical decision making

4 July 2026
Author(s): Marcel Levi

Artificial intelligence (AI) applications bear a great promise for healthcare. If successfully implemented, AI could reduce the workload for healthcare professionals and enhance the quality of work... more

A clinically oriented review of cystatin c in hospitalized adults: when creatinine misleads—A practical guide for internists and its role in heart failure risk stratification

10 June 2026
Author(s): Michael A. Acevedo Monsanto, Eric C. Zuberi, Albert Bui, Maria Vitoria Coutinho, Camily Morales Lopez, Michael A. Mao, Kamal Shair

Accurate assessment of kidney function is essential in hospitalized patients. However, serum creatinine does not always reflect true kidney function because it can be influenced by factors such as... more

Physical activity in older patients: Push your performance capacity to prevent and limit frailty!

4 June 2026
Author(s): FD Desgorces, A Gouelle, SJ Moss, P Noirez

Optimal aging is characterized by older adults maintaining good functional reserves, complete independence, and physiological resilience to stress. Conversely, some elderly individuals exhibit... more

Letter to the Editor

Deprescribing after hypotensive syncope: Recurrence burden and ambulatory blood pressure targets

1 September 2026
Author(s): Sevval Altay

The multicentre, prospective study by Russo et al. [1] evaluated a deprescribing strategy supported by ambulatory blood pressure monitoring in 92 hypertensive patients with severe hypotensive syncope... more

Urinary albumin-to-creatinine ratio in heart failure: Methodological and clinical considerations

31 August 2026
Author(s): Can Lu, Jun Guo

We read with great interest the study by Rubio-Gracia J et al., which evaluated the prognostic significance of the urinary albumin-to-creatinine ratio (UACR) in the RICA-2 heart failure (HF) registry... more

Prurigo nodularis: time to look beyond the skin—towards cardiovascular and metabolic comorbidity

31 August 2026
Author(s): Inês Tribolet de Abreu, Paulo Filipe

Prurigo nodularis (PN) is increasingly recognised as a systemic disease marker rather than an isolated dermatological disorder. Although the dominant clinical manifestation is chronic, often severe... more

Early allopurinol in asymptomatic hyperuricemia: caution in interpreting modelled cardiorenal benefits

29 August 2026
Author(s): Cong Liu, Chengqiang Jin

We read the article by Inotai et al. with interest [1]. Whether allopurinol should be started before the first gout flare is a practical question, especially in people already at high cardiovascular... more

Malnutrition predicts adverse clinical outcomes in older patients hospitalized in internal medicine wards

28 August 2026
Author(s): Carlotta Franchi, Sara Mandelli, Alessandro Nobili, Pier Mannuccio Mannucci, Ilaria Ardoino, REPOSI Investigators

Dear Editor, malnutrition is a frequent but often overlooked condition among hospitalized older adults that substantially affects their prognosis [1,2]. Patients admitted to internal medicine wards... more

Can device-derived digital biomarkers detect physiological response to SGLT2 inhibition in heart failure?

27 August 2026
Author(s): Ursula Rohrer, Katharina Ingrid Gölly, Markus Stühlinger, Dirk von Lewinski, Daniel Scherr, for the ERASe study group

Heart failure (HF) remains a leading cause of morbidity and mortality despite substantial advances in guideline-directed medical therapy [1]. Alongside therapeutic developments, cardiac implantable... more

Reconsidering the interpretation of prescribing shifts and treatment response in the AMBI-RA study. Authors’ reply

24 August 2026
Author(s): Riccardo Bertola, Carlo Garaffoni, Beatrice Maranini, Alessandra Bortoluzzi, Ettore Silvagni

We read with great interest the letter by Huang M. et al. [1] on the AMBI-RA study by our group [2], and we are grateful for their comments which permit to better elucidate the significance of our... more

Orthostatic hypotension in heart failure: Moving from prevalence to phenotype

24 August 2026
Author(s): Jiaqi Shen, Zhichao Zhao, Ting Shen, Fangfang Huang

To the Editor Coscetta and colleagues provide the first systematic estimate of orthostatic hypotension (OH) in patients with heart failure (HF), pooling nine studies (10 cohorts; 2036 patients) and... more

Protein supplementation and diaphragmatic function in hospitalized older adults

20 August 2026
Author(s): Fábio C. de Assis, Saulo Gil, Priscila Vieira Loureço dos Reis, Luciano F. Drager, Alexandre Anderson de Souza Munhoz Soares

Acute hospitalization accelerates muscle loss in older adults through inflammation, immobility, inadequate nutritional intake, and anabolic resistance. Respiratory muscles may also be affected,... more

Should LDL cholesterol targets be individualized according to bleeding risk?

13 August 2026
Author(s): Carmine Siniscalchi

The recently published Ez-PAVE trial has further consolidated one of the fundamental principles of cardiovascular prevention by demonstrating that an intensive low-density lipoprotein cholesterol (... more

First UK report of Imlifidase-enabled deceased donor kidney transplantation in highly sensitised recipients

12 August 2026
Author(s): Asha Mohan, Clare Collins, David Briggs, Nithya Krishnan, Atul Bagul

Dear Editor

Pulmonary artery diameter and sudden death in PAH: Is 40 mm a true threshold or a warning value?

10 August 2026
Author(s): Hongquan Xing, Xiaoqun Ye

We read with great interest the study by Dardi and colleagues investigating the haemodynamic determinants and prognostic implications of pulmonary artery dilation in pulmonary arterial hypertension (... more

Serum uric acid trajectories in women: Why elevated levels in younger women warrant attention

8 August 2026
Author(s): Anna Vittoria Mattioli, Claudio Borghi

Serum uric acid (SUA) is usually interpreted as a single measurement against a fixed threshold. In women, however, this static approach may be particularly misleading. SUA follows a dynamic course... more

Comparable 1-year effectiveness of tezepelumab and dupilumab after anti–IL-5/IL-5Rα biologic failure in severe asthma

8 August 2026
Author(s): Po-Cheng Shih, Shih-Pin Chen, James Cheng-Chung Wei

Since 2003, multiple biologics targeting specific inflammatory pathways have been developed for severe asthma. Despite guideline-recommended selection based on clinical characteristics and biomarkers... more

Reflections on left atrial enlargement. Authors’ reply

7 August 2026
Author(s): Bianca Clerici, Gian Marco Podda

Dear Editor,

Hemodynamic renal adaptation, cardiorenal pharmacotherapy, and the case for structured monitoring in HFrEF

6 August 2026
Author(s): Shanti Bhushan Mishra

We read with great interest the reply by Russo et al. [1], in which the authors addressed comments on their review of renal protection strategies in heart failure with reduced ejection fraction (... more

Clarifying the lipid signal: non-HDL cholesterol, remnant cholesterol and metabolic risk in primary care

3 August 2026
Author(s): Fuad A. Abdu

I read with great interest the study by Baeza-Delgado et al. [1], which assessed the prevalence of elevated non-high-density lipoprotein cholesterol (non-HDL-C) in 820,318 individuals not receiving... more

Candida bloodstream infection in older adults: sex as a pathway marker, not a mortality shortcut

28 July 2026
Author(s): Zhichao Zhao, Ting Shen

We read with great interest the multicentre analysis by Bartalucci and colleagues, who evaluated sex-based differences and 30-day mortality in 1132 adults aged 65 years or older with Candida... more

Abatacept in RA-ILD: defining rather than assuming a pulmonary window of opportunity

27 July 2026
Author(s): Shuting Kong, Kepeng Yang

We read with great interest the multicentre study by Serrano-Combarro and colleagues evaluating abatacept in rheumatoid arthritis-associated interstitial lung disease (RA-ILD). The authors should be... more

Factor XIa inhibitors after acute non-cardioembolic ischemic stroke or high-risk TIA

25 July 2026
Author(s): Ahmed Emara, Ahmed Mansour, Ameer Awashra, Ahmed Adel Abdel Azim, Abdalhakim Shubietah

Dear Editor,

Dismantling the routine use of prophylactic volume expansion in contrast-associated acute kidney injury. Author's reply.

24 July 2026
Author(s): Telma H Ragnarsdottir, Runolfur Palsson, Olafur S Indridason, on behalf of all authors

Dear Editor,

Lower incidence of venous thromboembolism in hospital-at-home patients: Do unequal detection opportunities and between-group non-equivalence affect the interpretation of the findings? Author's Reply

24 July 2026
Author(s): Joao Modesto dos Santos, Iñigo Les Bujanda, Ramón Lecumberri Villamediana, Silvia Salinas Urra, María Ruiz Castellano

Dear Editor,

Retatrutide and the urinary tract infection signal: Is the answer hidden in timing?

23 July 2026
Author(s): Theocharis Koufakis, Georgia Argyrakopoulou, Alexander Kokkinos, Carel W. le Roux

Dear editor,

Persistent hyponatremia at discharge: Undertreatment or unresolved diagnosis?

23 July 2026
Author(s): Enmanuel A. Leiva-Murillo, Carles Cebrián i Jerónimo, Marina Gregori-Jonama, Karamjot Singh-Kaur

Dear Editor,

Beyond fixed BMI cutoffs after paroxysmal atrial fibrillation ablation

23 July 2026
Author(s): Ying Huang, Hongping Wang, Yanzheng Song, Xiaochun Han, Liangqing Guo

Dear Editor,

The missing piece in severe acquired brain injury care: Integrating neurophysiological screening for critical illness polyneuropathy and myopathy. Author’s reply

21 July 2026
Author(s): Camilla Grifoni, Angela Comanducci, Luca Bucciardini

We thank Messina for his insightful comments on our recent article describing a novel Neuro-ICU-Neurorehabilitation Unit (INRU) co-management model for patients with severe acquired brain injury (... more

The denominator matters: Interpreting urinary albumin-to-creatinine ratio in older patients with heart failure

21 July 2026
Author(s): Fei Yang, Haoyang Hu

We read with great interest the study by Rubio-Gracia and colleagues examining the clinical and prognostic significance of the urinary albumin-to-creatinine ratio (UACR) in patients with heart... more

The challenge of innovation in lupus between abstraction and reality

20 July 2026
Author(s): Giuseppe A. Ramirez, Luca Moroni, Enrica P. Bozzolo, Marco Matucci-Cerinic, Lorenzo Dagna

“He that will not apply new remedies, must expect new evils.”Francis Bacon, Essays, “Of Innovations”, 1625.

Cultural congruence in mindfulness-based interventions for diabetes-related distress

18 July 2026
Author(s): Aamer Aldbyani

We read with interest the pilot study by Kortegaard et al. [1] on a group-based intervention targeting diabetes-related emotional distress among emerging adults with type 1 diabetes. While the study... more

In-flight human physiology at high-altitudes: not everyone should fly

18 July 2026
Author(s): Anna Teresa Mazzeo, Danilo Spanu, Deepak Gupta

Dear Editor,

Beyond comorbidities: Age as an independent predictor of survival in pulmonary arterial hypertension

17 July 2026
Author(s): Rafael Bravo-Marqués, Francisco Rivas-Ruiz, Eva Gutierrez-Ortiz, Isabel Blanco, Pilar Escribano-Subías

Dear Editor,

Reconsidering stepwise lipid-lowering titration and outpatient adherence dynamics after acute myocardial infarction

16 July 2026
Author(s): Hui Wang, Shuxiong Ge

We read with great interest the recent multicenter quality improvement audit by Gragnano and colleagues regarding diagnostic and therapeutic inertia in low density lipoprotein cholesterol management... more

Rethinking residual sex effects in frailty-adjusted ICU mortality

14 July 2026
Author(s): Jing Pang

Dankl et al. provide a valuable frailty-adjusted analysis of sex and 30-day mortality in older critically ill adults, and the combination of frequentist and Bayesian estimates is a particular... more

Does T90 reflect OSA-specific hypoxic burden or underlying pulmonary disease? Author's reply

13 July 2026
Author(s): Francesco Bertoldo, Giulia Sartori, Matteo Lombini, Alberto Fantin, Ernesto Crisafulli

Dear Editor,

Interpreting the neutrophil-to-lymphocyte ratio in stable chronic obstructive pulmonary disease: Severity, case mix, and clinical utility

10 July 2026
Author(s): Kunlong Zhang, Xiaoqi Ying, Boxu Lang

We read with interest the retrospective study by Vanetti et al. [1], which evaluated the neutrophil-to-lymphocyte ratio (NLR) in 247 clinically stable patients with chronic obstructive pulmonary... more

Using latent class analysis for identifying clinical phenotypes associated with prognosis in patients with atrial high-rate episodes

3 July 2026
Author(s): Wenhui Li, Amir Askarinejad, Yanda Meng, Majid Haghjoo, Gregory Y.H. Lip, on behalf of The Liverpool AF Project Group

Atrial high-rate episodes (AHRE) detected by cardiac implantable electronic devices are frequently encountered in clinical practice [1,2] and are associated with an increased risk of atrial... more

Severe hyperkalaemia during liposomal amphotericin B treatment, independent of nephrotoxicity

2 July 2026
Author(s): C. Gourjault, T. Pietri, J. Carvelli, S. Ranque, N. Cassir

Dear Editor,

Artificial intelligence and clinical responsibility in the multimorbid patient

1 July 2026
Author(s): Domingo Ruiz-Hidalgo, Ramon Pujol Farriols, Roberto Elosua Llanos

Artificial intelligence (AI) is not simply transforming clinical practice; it is reshaping how clinical responsibility is organised. Much of the current debate has focused on whether AI will replace... more

Risk reclassification and implementation challenges in the 2026 AHA/ACC pulmonary embolism guideline

30 June 2026
Author(s): Nicola Mumoli, Lucia Colavolpe, Francesco Dentali

The recently published 2026 AHA/ACC guideline for the evaluation and management of acute pulmonary embolism (PE) introduces several conceptual innovations that may influence clinical practice beyond... more

Recurrent Pericarditis, Hydroxychloroquine, and the Unrecognized Risk of Myasthenia Gravis

30 June 2026
Author(s): Christian Messina

We read with great interest the article by Trotta et al. evaluating the role of hydroxychloroquine (HCQ) in recurrent pericarditis (RP), as well as the accompanying commentary by Tan et al. [1,2].... more

Obstructive sleep apnea syndrome as the missing piece in the puzzle of cardiovascular–kidney–liver–metabolic syndrome

29 June 2026
Author(s): Dimitrios Patoulias, Caterina Conte, Alexandra Kautzky-Willer

Dear Editor, the staging framework of cardiovascular–kidney–metabolic (CKM) syndrome initially proposed by the American Heart Association in November 2023 represents an impressive conceptual advance... more

“Non-reproducible mortality data in a hyponatremia–TBI meta-analysis”. Author's Reply

28 June 2026
Author(s): Erika Zornoza-González, Alicia Saz-Lara, Iván Cavero-Redondo, Iris Otero-Luis

We would like to thank Huang et al [1] for their careful review of our systematic review and meta-analysis [2] and for raising concerns regarding the presentation and reproducibility of the mortality... more

Considerations regarding the diagnosis of short telomere syndrome in a patient with opportunistic infections

28 June 2026
Author(s): Salvatore Chirumbolo

The recent manuscript by Belhabib et al., presents an interesting and educational case of opportunistic infections associated with severe CD4+ lymphocytopenia, yet the central conclusion, that the... more

Interpreting echocardiographic improvement in EGPA: pulmonary vascular reversal, cardiac involvement, or disease activity?

28 June 2026
Author(s): Enmanuel A. Leiva-Murillo, Oriol Ventosa-Blázquez

We read with interest the study by Carlucci et al., “Eosinophil-linked pulmonary circulation in EGPA Improves under anti-IL-5/R therapy: A longitudinal study” [1]. The authors should be commended for... more

Twelve-year trends in sex and age of patients with COPD and chronic respiratory failure undergoing pulmonary rehabilitation

26 June 2026
Author(s): Matteo Vigna, Gaia Riboni, Valentina Tibollo, Riccardo Bellazzi, Michele Vitacca

Dear Editor,

The missing piece in severe acquired brain injury care: Integrating neurophysiological screening for critical illness polyneuropathy and myopathy

18 June 2026
Author(s): Christian Messina

We read with great interest the recent article by Grifoni and Bucciardini, regarding the implementation of an interdisciplinary co-management model between the Neuro-Intensive Care Unit (Neuro-ICU)... more

Readmission risk after protected discharge: are multidimensional tools superior to functional scales?

16 June 2026
Author(s): Gianluca Azzellino, Patrizia Vagnarelli, Ernesto Aitella, Lia Ginaldi, Massimo De Martinis

Early hospital readmissions remain one of the major challenges for healthcare systems and are widely recognized as an indicator of healthcare quality, effective discharge planning, and continuity of... more

Non-reproducible mortality data in a hyponatremia–TBI meta-analysis

16 June 2026
Author(s): Mai Huang, Xin Gan, Zhicheng Huang

Dear Editor,

Logistic regression ignores time-to-event in competing risks analysis

16 June 2026
Author(s): Zheqi Zhang, Zaiyou Qian, Jing Ma

We read with interest the study by Brunetti et al. on oral anticoagulant (OAC) nonprescription in older atrial fibrillation patients with reduced expected survival [1]. The authors should be... more

Optical coherence tomography angiography in systemic sclerosis: from a microvascular signal to clinical utility

15 June 2026
Author(s): Shinya Yamaguchi, Shizuka Yamamoto, Rindai Saito, Hiroshi Ito

Comment on.

Baseline or dynamic prediction after venous thromboembolism? Clarifying the clinical use of the CAVE score for occult cancer

15 June 2026
Author(s): Hongquan Xing, Xiaoqun Ye

Jara-Palomares and colleagues should be congratulated for developing and externally validating an international score to estimate the risk of cancer within one year after venous thromboembolism (VTE... more

The time has come for comprehensive geriatric assessment in internal medicine

12 June 2026
Author(s): Chiara Ceolin, Marina De Rui, Sandro Giannini, Paolo Simioni, Giuseppe Sergi

Complexity has become a defining feature of modern internal medicine. Older adults with multimorbidity, polypharmacy, biological and functional vulnerability, and multidimensional frailty now... more

Have mediators and at-risk time shaped the Lipoprotein(a)-dementia null?

11 June 2026
Author(s): Yunguang Wang, Yiwei Shang, Shengliang Qiu

Rossi and colleagues report no association between elevated lipoprotein(a) [Lp(a)] and incident dementia in a large propensity-score-matched TriNetX cohort [1]. The study is valuable because Lp(a) is... more

Lower incidence of venous thromboembolism in hospital-at-home patients: Do unequal detection opportunities and between-group non-equivalence affect the interpretation of the findings?

9 June 2026
Author(s): Manchao Liu

We read with great interest the prospective cohort study by Dos Santos et al. published in the European Journal of Internal Medicine [1]. This study focused on VTE risk assessment in patients with... more

Hydroxychloroquine for recurrent pericarditis

5 June 2026
Author(s): Lucia Trotta, Francesco Agozzino, Ruggiero Mascolo, George Lazaros, Antonio Brucato

We thank Zhang and Xu [1,2] for their interest in our work [3]. Regarding the observations of Zhang [1], we agree that observational studies can suggest that a treatment may be beneficial but cannot... more

GLP-1 receptor agonists for the management of obesity in individuals treated with antipsychotics

2 June 2026
Author(s): Dimitrios Patoulias, Eleftherios Teperikidis, Michail-Angelos Mourtzos, Theocharis Koufakis, Paschalis Karakasis

Individuals with psychotic disorders treated with antipsychotic drug classes are at high risk for developing overweight/obesity and related cardiometabolic complications, resulting in excess... more

Dismantling the routine use of prophylactic volume expansion in contrast-associated acute kidney injury

30 May 2026
Author(s): Bassel Dahha, Mohamad Bassel Dahha, Gharam Abdulaziz Alahmadi, Mohammed Abu Shakir, Yousef Talal Rajikhan

We read with profound clinical interest the recent prospective analysis by Ragnarsdottir et al., [1] in the European Journal of Internal Medicine regarding the evolving risk factors for hospital- and... more

Reporting clinical escalation in Hospital-at-Home: from a single rate to a structured framework

29 May 2026
Author(s): David Nicolás, Andrea Parra-Plaza, Ainoa Ugarte

Hospital-at-Home (HaH) programmes are expanding rapidly across European health systems as substitutive acute care models [1,2]. As they consolidate, unplanned transfer back to hospital — termed... more

Microplastics in drinking water: A silent threat amplifying health inequities in low-resource settings

22 May 2026
Author(s): Mohamed Daud Mohamed, Liibaan Abdulahi Sudi, Abdikadir Ahmed Hassan, Iqro Omar Ibrahim, Yakub Burhan Abdullahi

Microplastics have become ubiquitous contaminants in global drinking water supplies. Detected in tap water, bottled water, and untreated sources across both high- and low-income countries, these... more

Male hypogonadism and incretin therapy response

22 May 2026
Author(s): Sandro La Vignera, Rosita A. Condorelli

Dear Editor,

Coronary microvascular dysfunction as a plausible convergent mechanism in cancer therapy-related MINOCA: evidence synthesis and a call for diagnostic standardization

18 May 2026
Author(s): Fuad A. Abdu

Myocardial infarction with non-obstructive coronary arteries (MINOCA) accounts for 6–10 % of all acute myocardial infarctions (MI), carries a non-trivial long-term risk of major adverse... more

Evaluating the use of hydroxychloroquine in recurrent pericarditis: Methodological concerns and public health implications

15 May 2026
Author(s): Ping Zhang

We were highly interested in the article by Trotta et al. regarding the use of hydroxychloroquine (HCQ) for treating recurrent pericarditis (RP) [1]. The authors reported that HCQ significantly... more

Reconsidering the interpretation of prescribing shifts and treatment response in the AMBI-RA study

14 May 2026
Author(s): Mai Huang, Zhicheng Huang, Xin Gan

We read with great interest the AMBI-RA study by Bertola et al. [1], which examined changes in b/tsDMARD prescribing and short-term treatment outcomes after regulatory restrictions on Janus kinase... more

Initial misdiagnoses in Sjögren’s disease patients

14 May 2026
Author(s): Adrian Y.S. Lee

Sjögren’s disease (SjD) is a chronic systemic autoimmune disease affecting exocrine glands, causing sicca symptoms, arthralgias and fatigue. It is highly heterogenous and may have variable clinical... more

Paroxysmal atrial fibrillation and bleeding: Pattern, prescription, or both? A call for aspirin-informed analyses in COMBINE-AF

9 May 2026
Author(s): Michal Pruc, Karol Momot, Bartosz Maj, Lukasz Szarpak

Ntaios and colleagues report an exceptional individual patient-level analysis from COMBINE-AF (n = 71,466), providing unusually precise estimates of outcome gradients between paroxysmal atrial... more

Cumulative nocturnal hypoxemia, but not apnea-hypopnea index, is independently associated with vertebral fracture burden in obstructive sleep apnea

8 May 2026
Author(s): Francesco Bertoldo, Giulia Sartori, Matteo Lombini, Alberto Fantin, Ernesto Crisafulli

Obstructive sleep apnea (OSA) is a highly prevalent disorder characterized by recurrent upper airway collapse, intermittent hypoxemia, and sleep fragmentation [1]. Beyond its established... more

Timing of brain biopsy in cryptogenic neurological diseases: beyond diagnostic yield

4 May 2026
Author(s): Xin Wang, Sulong Zheng, Chao Sun

We read with great interest the study by Aboubakr et al [1] investigating the impact of brain biopsy timing on diagnostic yield and clinical outcomes in patients with neurological diseases of unknown... more

Rethinking renal protection in patients with heart failure and reduced ejection fraction

2 May 2026
Author(s): Wei Chen, Kexin Ye

We read with great interest the review titled “Renal protection in heart failure with reduced ejection fraction: not all that glitters is gold” by Elisa Russo and colleagues, published in your... more

Dialysis, but not severe renal dysfunction, is associated with excess bleeding in venous thromboembolism: Insights from a nationwide registry

2 May 2026
Author(s): Takahiro Kuno, Norimichi Koitabashi, Yugo Yamashita, Takeshi Morimoto, Hideki Ishii, on behalf of the COMMAND VTE Registry-2 Investigators

Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is a common and potentially fatal complication in patients with chronic kidney disease (CKD), including... more

Refining cerebrovascular risk in left atrial enlargement: integrating CKM framework and atrial cardiomyopathy phenotyping

24 April 2026
Author(s): Weikai Dong, Guangmin Yang, Qiang Wang

We read with great interest the article “Left atrial enlargement and 1-year cerebrovascular events in subjects without atrial fibrillation: A prospective cohort study” by Clerici et al. [1]. The... more

Uric Acid, Homocysteine, and comorbidities in sarcoidosis

21 April 2026
Author(s): Elias Giallafos, Ioannis Ilias, Evaggelos Oikonomou, Ourania Katsarou, Gerasimos Siasos

Sarcoidosis (SA) is a multisystem granulomatous disease with a highly variable clinical course. To-date, there are no validated circulating biomarkers capable of reliably predicting long-term outcome... more

Beyond survival: nuances in the robustness of SGLT2 inhibitor evidence for HFpEF

20 April 2026
Author(s): Qi Sun, Longqing Yu

We read with great interest the article by Zuin et al., which provides a rigorous evaluation of the robustness of randomized controlled trial (RCT) evidence for sodium-glucose co-transporter 2... more

Universities and healthcare as privileged war targets. An urgent call for an international academic and institutional response to the attack on the Lebanese University and the health system

13 April 2026
Author(s): Mohamad Khalil, Agostino Di Ciaula, Piero Portincasa

Attacks on universities during armed conflicts represent a profound threat to individual lives but also to the institutions that sustain knowledge, scientific progress, and social stability [1]. In... more

Pathophysiological and prognostic implications of psychological distress in non-obstructive coronary syndromes: When the mind breaks the heart

4 April 2026
Author(s): Fuad A. Abdu, Abeer Essam Noman, Naif S. Al-barha, Aamer Aldbyani

Cardiovascular disease remains the leading cause of death worldwide [1], yet the field’s diagnostic and treatment strategies continue to target obstructive epicardial coronary artery disease... more

Methodological considerations for translating the STAMP score in intermediate-high-risk pulmonary embolism

30 March 2026
Author(s): Xiuhua Wang, Meiying Wang

We read with interest the study by Zuin and colleagues reporting the STAMP score for predicting 48-hour clinical deterioration in hemodynamically stable patients with intermediate-high-risk acute... more

From structure to function: A commentary on left atrial enlargement and cerebrovascular events and the potential value of left atrial strain

28 March 2026
Author(s): Man Luo, YiHuai Tian, Xun Ou

I read with great interest the article by Clerici and colleagues titled "Left atrial enlargement and 1-year cerebrovascular events in subjects without atrial fibrillation: A prospective cohort study... more

Original Article

Phenotypic clustering and ABC pathway adherence in patients with atrial fibrillation at high risk of bleeding and stroke: Insights from three global registries

30 August 2026
Author(s): Amir Askarinejad, Tommaso Bucci, Enrico Tartaglia, Andrea Galeazzo Rigutini, Michele Rossi, Hung-Fat Tse, Majid Haghjoo, Giuseppe Boriani, Tze-Fan Chao, Gregory Y.H. Lip

Patients with atrial fibrillation (AF) who are at increased risk of both thrombotic and haemorrhagic events represent a heterogeneous and broad clinical entity, characterized by the presence of... more

Long-term vascular outcomes and biological predictors of thrombosis in systemic lupus erythematosus: a 10-year prospective cohort study

28 August 2026
Author(s): Leyre Riancho-Zarrabeitia, Nuria Vegas-Revenga, Lucía Domínguez-Casas, Alfonso Corrales, Carmen Bejerano, Iñigo Gonzalez-Mazón, Alex GarcíaTellado, Carmen Valero, José L Hernández, Ricardo Blanco

Systemic lupus erythematosus (SLE) is associated with increased cardiovascular morbidity, but the long-term prognostic value of subclinical atherosclerosis and circulating biomarkers remains... more

Recurrent venous thromboembolism and bleeding during anticoagulation in patients with deep-vein thrombosis treated with vitamin K antagonists or direct oral anticoagulants: insights from the RIETE registry

28 August 2026
Author(s): Paolo Prandoni, Raffaele Pesavento, Franca Bilora, Benjamin Brenner, Iria Francisco, Germán Sierra-Palomares, Ángeles Fidalgo, Jana Hirmerova, Samuel Fonseca, Manuel Monreal, the RIETE Investigators

Randomized trials have shown that direct oral anticoagulants (DOACs) are as effective as vitamin K antagonists (VKAs) for treating venous thromboembolism (VTE), with less major bleeding. Whether... more

Steroid-sparing biologics in severe asthma and chronic obstructive pulmonary disease: a systematic review, cross-disease meta-analysis, and translational estimate of corticosteroid-related harm prevented

24 August 2026
Author(s): Pier-Valerio Mari, Lorenzo Carriera, Angelo Coppola, Davide Onofrio Fontana, Simone Ielo, Alberto Ricci, Veronica Ojetti, Umberto Semenzato, Francesco Menzella, Stefano Baglioni, Cecilia Becattini, Eugenio De Corso

Oral corticosteroids (OCS) remain widely used in uncontrolled severe asthma and frequently exacerbating chronic obstructive pulmonary disease (COPD), but cumulative exposure is associated with dose-... more

Long-term mortality in patients admitted acutely for chronic liver disease in England: A national cohort study

24 August 2026
Author(s): Cori Campbell, Benjamin Palafox, Vikram Bains, James Doidge, Jan van der Meulen, Kate Walker, William Bernal

Mortality of CLD patients after a FEA in England is exceptionally high, with marked differences according to sociodemographic characteristics, aetiology, disease severity, and geographic region.... more

Effects of bariatric surgery on apolipoprotein A1, apolipoprotein B, and apolipoprotein B/ apolipoprotein A1 ratio: Findings from a prospective cohort

22 August 2026
Author(s): José Ignacio Martínez-Montoro, Alba Rodriguez-Muñoz, Mario Gutiérrez-Bedmar, Nerea Ruiz-Campos, Luis Ocaña-Wilhelmi, Diego Fernández-García, Juan Manuel Blanco-Millán, Ángela Núñez-Morales, Dieter Morales-García, Francisco J. Tinahones, Lourdes Garrido-Sánchez, Carolina Gutiérrez-Repiso

Bariatric surgery is associated with significant improvements in cardiometabolic health. The apolipoprotein B (ApoB)/apolipoprotein A1 (ApoA1) ratio has been demonstrated to be a strong predictor of... more

Comparative risks of dementia and Parkinson’s disease with GLP-1 RAs versus other oral glucose-lowering medications in obese patients with type 2 diabetes: a large real-world cohort study

21 August 2026
Author(s): Wiessam Abu Ahmad, Yael Wolff Sagy, Ronen Arbel, Erez Battat, Dror Dicker, Gil Lavie, Orna Reges

This study evaluates dementia and Parkinson's disease (PD) risk among patients with type 2 diabetes (T2D) and obesity initiating GLP-1 receptor agonists (GLP-1 RAs) compared with other oral glucose-... more

Sex-specific differences in the clinical and psychiatric phenotype of hospitalized patients admitted to a tertiary alcohol-related disease unit

13 August 2026
Author(s): Margherita Vergadoro, Chiara Ceolin, Simona Di Liberto, Giovanni Gottardi, Benedetta Perotti, Anna Franceschini, Luca Fabris, Luca Spiezia, Erika Zola, Paolo Simioni

Alcohol Use Disorder (AUD) is a chronic disease characterized by impaired control over alcohol intake, cravings, and continued use despite physical, psychological, and social consequences [1].

Hospitalisation and healthcare use in persons screened for atrial fibrillation compared with usual care

13 August 2026
Author(s): Emilie Katrine Kongebro, Christian Kronborg, Thomas Clement Truelsen, Ketil Jørgen Haugan, Claus Graff, Søren Højberg, Axel Brandes, Lars Køber, Christian Torp-Pedersen, Jesper Hastrup Svendsen, Søren Zöga Diederichsen

The impact of screening for incident atrial fibrillation (AF) on healthcare use and hospitalisation is largely unknown.

“Hospital-at-home and 30-day readmission among clinically eligible patients: a prospective cohort study with a capacity-constrained comparator group”

11 August 2026
Author(s): Pablo Rodríguez-Cortés, Elena Arranz Canales, Alexia Constanza Espiño Álvarez, Javier Bernardo Pérez-Serrano, Laura Rabes-Rodríguez, Marta Fernández Rico, Eva María Fernández Bermejo, Ángela Sánchez Juez, Victoria Gutiérrez Gómez-Lus, Fernando Ruiz Berraco, Saida Alonso Marrero, Jaime Bustos Carpio, Carmen Sáez Béjar, José María Galván-Román, Fernando Sebastian-Valles

To evaluate the association between hospital-at-home (HaH) care and unplanned 30-day hospital readmission using a capacity-based comparator group of clinically eligible patients admitted to... more

Prevalence and incidence of diabetes in patients with non-functional adrenal tumors

11 August 2026
Author(s): Fredrik Sahlander, Ana Carasel, Buster Mannheimer, Jonatan D. Lindh, Henrik Falhammar

The association between non-functional adrenal tumors (NFAT) and diabetes is unclear.

Deprescribing of blood pressure-lowering medications in patients with hypotensive syncope

11 August 2026
Author(s): Vincenzo Russo, Erika Parente, Angelo Comune, Antonella Groppelli, Jaume Francisco-Pascual, Nuria Rivas-Gándara, Jean-Claude Deharo, Baptiste Maille, Frederik J. De Lange, Thomas T. Boel, Giulia Rivasi, Mattia Laffi, Roberto Maggi, Rose Anne Kenny, Artur Fedorowski, Gianfranco Parati, Michele Brignole

The hypotensive phenotype of autonomic syncope is characterized by hypotension as the predominant hemodynamic mechanism underlying loss of consciousness [1,2]. The term hypotensive phenotype... more

Prevalence of orthostatic hypotension in heart failure: a systematic review and meta-analysis

4 August 2026
Author(s): Federica Coscetta, Bernadette Corica, Andrea De Mare, Valeria De Grazia, Giordana Iannibelli, Stefano Negri, Francesco Murru, Andrea Salzano, Antonio Cittadini, Marco Proietti, Alberto Maria Marra

Orthostatic hypotension (OH), defined as a reduction in systolic/diastolic blood pressure ≥20/10 mmHg upon standing, is common in older adults and may interfere with the optimization of guideline-... more

Educational professional activities for enhancing heart failure guidelines implementation: data from the Optimization of Therapy in the Italian Management of Heart Failure (OpTIMa-HF) Registry

4 August 2026
Author(s): Stefania Paolillo, Federica Marzano, Dario Bruzzese, Gennaro Galasso, Franco Guarnaccia, Giosuè Santoro, Paolo Severino, Piergiuseppe Agostoni, Savina Nodari, Federico Guerra, Paolo Calabrò, Gianfranco Sinagra, Roberta Montisci, Giuseppe Patti, Michele Senni, Pasquale Perrone Filardi, on behalf of the OpTIMa-HF Investigators

European guidelines recommend for heart failure with reduced ejection fraction (HFrEF) rapid initiation and later up-titration of four foundation drugs. We assessed whether an educational... more

Cardiac rehabilitation referral and access by country income class: Comparisons from the International Council of Cardiovascular Prevention and Rehabilitation’s 2025 Global Audit Update

31 July 2026
Author(s): Rachael P. Carson, Sherry L. Grace, Karam Turk Adawi, Mariya P. Jiandani, Lilian Mbau, Jimena Martinez, Monserrat Cruz Rivero, Claudia V. Anchique, Rongjing Ding, Dinah L. van Schalkwijk, Jonathan Gallagher, Won-Seok Kim, Pamela Seron, Lela Maskhulia, Emil Hagström, Arto Hautala, Yoshihiro Fukumoto, Gabriela L.M. Ghisi

To characterize CR: (1) referral practices, (2) systematic referral barriers, (3) wait listing, (4) program-level approaches to mitigating patient access barriers, as well as (5) CR reimbursement... more

Biological therapy in Takayasu arteritis. Results from the REVAS registry

30 July 2026
Author(s): J Mestre-Torres, JL Callejas-Rubio, M Pérez-Conesa, B de Escalante-Yangüela, A Núñez-Conde, F Martínez-Valle, EM Fonseca-Aizpuru, R Solans-Laqué

Biological therapy in patients with Takayasu arteritis is frequently used, but the factors associated with its use have not been determined. The present study aims to describe and identify predictors... more

Exercise-based prehabilitation programs reduce hospital stay and postoperative complications in surgical patients with cancer: a systematic review and meta-analysis

29 July 2026
Author(s): Manuel Fernandez-Escabias, Sofia Carrilho-Candeias, Cristian Garcia-Sanchez, Andrea Orellana-Jaen, Alberto Millan-Martin, Almudena Carneiro-Barrera, Jonatan R Ruiz, Francisco J Amaro-Gahete

Cancer prevalence and mortality rates are rapidly increasing worldwide, making it a leading cause of morbidity and death [1]. Although surgery is considered the primary treatment for most cancers [2... more

The cardio-hepatic syndrome and right ventricular dysfunction in heart failure with mildly reduced ejection fraction

24 July 2026
Author(s): Tobias Schupp, Henning Johann Steffen, Noah Abel, Alexander Schmitt, Marielen Reinhardt, Felix Lau, Michelle Goertz, Jonas Dudda, Kathrin Weidner, Mohammad Abumayyaleh, Jonas Rusnak, Michael Behnes, Ibrahim Akin

Right ventricular dysfunction (RVD) is common in patients with heart failure (HF) and reduced ejection fraction and may lead to cardio-hepatic syndrome (CHS). The present study investigates the... more

Weight-adjusted fluid balance and its impact on days alive without life support in critical illness – an observational cohort study

23 July 2026
Author(s): Debora M. Hofer, Mathieu Pitteloud, Martin Faltys, Alessandro Ostini, Jan Waskowski, Anna S. Messmer, Carmen A. Pfortmueller

In the last decade, intravenous fluid therapy in critically ill patients and its adverse side effects have received increasing attention. The total of resuscitation fluids, maintenance fluid therapy... more

Subclinical hypotension in acute decompensated heart failure: prognosis and treatment implementation

21 July 2026
Author(s): Giulio Savonitto, Davide Stolfo, Mattia Emanuele Biber, Daniele Cocianni, Stefano Contessi, Maria Perotto, Jacopo Giulio Rizzi, Elisa Soranzo, Marco Masè, Marco Merlo, Gianfranco Sinagra

Patients hospitalized for acute decompensated heart failure (ADHF) with low blood pressure (BP) represent a clinically challenging yet frequently encountered subgroup in daily practice [1,2].... more

Impact of ECOG performance status on cancer-associated thrombosis treated with DOACs: Data from a multicenter cohort study

16 July 2026
Author(s): Rosa Talerico, Francesco Mancinetti, Clara Sacco, Matteo Mazzetti, Elena Campello, Simone Birocchi, Sofia Beccatini, Angelo Porfidia, Corrado Lodigiani, Paolo Simioni, Gian Marco Podda, Isabella Mastandrea, Cecilia Becattini, Roberto Pola, Maria Cristina Vedovati

Data on safety and effectiveness of direct oral anticoagulants (DOACs) in patients with cancer-associated thrombosis (CAT) and impaired functional status are limited. We evaluated the impact of... more

non-HDL-C: The missing parameter in primary care

16 July 2026
Author(s): Carlos Baeza-Delgado, Inma Sauri, Javier Diaz, Antonio Fernandez, Maria Jose Forner, Fernando Martinez, Sergio Martinez, Josep Redon

Lipid assessment forms part of routine healthcare assessments of the general population, primarily to identify the risk of atherosclerotic cardiovascular disease (ASCVD). It is recommended that these... more

Adipose tissue and adherence to the Mediterranean diet: Key factors for sleep quality in Polyendocrine Metabolic Ovarian Syndrome (PMOS)?

11 July 2026
Author(s): Ludovica Verde, Martina Galasso, Annamaria Colao, Luigi Barrea, Giovanna Muscogiuri

Sleep disturbances are common findings in women with Polyendocrine Metabolic Ovarian Syndrome (PMOS), though mechanisms remain unclear. This observational case-control study aimed to identify... more

Clinical and prognostic significance of urinary albumin-to-creatinine ratio in heart failure: insights from the RICA-2 registry

10 July 2026
Author(s): Jorge Rubio-Gracia, Marta Sánchez-Marteles, Beatriz Seoane, Iria Rodríguez, Jose Manuel Cerqueiro, Ana Suárez-Lombraña, Cristina Sánchez-Sánchez, Ivan Suárez-Pereira, Jose Pérez-Silvestre, Joan Carles Trullas

Heart failure (HF) is frequently accompanied by renal dysfunction and systemic congestion, reflecting the complex interaction between the heart and the kidneys within the cardiorenal syndrome. The... more

Diagnosis, treatment and outcomes of euvolemic hyponatremia among geriatric hospitalised patients

4 July 2026
Author(s): Damiano Astolfi, Jonathan Dash, Antonio Leidi, Véronique Trombert, Christophe Graf, Sandra De Breucker

Hyponatremia is the most common electrolytic disturbance among inpatients. It is associated with poor outcomes in frail older patients, even for mild disturbances. Prevalence increases with age, and... more

Sex-based differences and clinical outcomes in older adults with Candida bloodstream infection: a post-hoc secondary analysis of a multicentre study

3 July 2026
Author(s): Claudia Bartalucci, Jon Salmanton-García, Giusy Tiseo, Marco Falcone, Marco Muccio, Laura Caldararo, Daniele Roberto Giacobbe, Luca Bucci, Jesus Guinea, Malgorzata Mikulska, Maricela Valerio, Emilio Bouza, Patricia Muñoz, Jordi Rello, Matteo Bassetti, Antonio Vena, ESCMID Fungal Infection Study Group (EFISG) and ESCMID Study Group for Infections in the Elderly (ESGIE)

Candida bloodstream infections (BSI) are a major cause of disease in hospitalized patients, with particularly high morbidity and mortality among older adults. However, the impact of biological sex on... more

Low-renin hypertension in incidental adrenal adenomas and response to aldosterone-targeted therapy: a prospective study

27 June 2026
Author(s): Thomas Uslar, Benjamín Sanfuentes, Roberto Olmos, Alberth Burnier, Pauline Böhm, Francisco J. Guarda, Álvaro Huete, Nicolás Mertens, Cecilia Besa, Marcelo Andía, Alejandro Majerson, Jaime Cartes, Alejandra Tapia-Castillo, Cristian A. Carvajal, Carlos E. Fardella, Fidel Allende, Sandra Solari, Anand Vaidya, Rene Baudrand

Incidental adrenal adenomas are common, yet renin status is infrequently assessed in hypertensive patients. Emerging evidence supports a spectrum of renin-independent aldosterone excess associated... more

Pharmacokinetic robustness of direct oral anticoagulants vs. phenprocoumon in the emergency setting: impact of renal and hepatic impairment

27 June 2026
Author(s): Fatma Merzou, Luca Tarantini, Benjamin Landau, Martin Lesmeister, Hanna Martin, Thomas Bertsch, Shrey Mathur, Sergiu Groppa, Yaroslav Winter, Klaus Fassbender, Piergiorgio Lochner

Direct oral anticoagulants (DOACs) are increasingly used, but their pharmacokinetic stability compared to vitamin K antagonists during acute illness remains poorly characterized. We aimed to evaluate... more

SARS-CoV-2 infection, viral burden, and variant-specific outcomes in hospitalized patients with heart failure

24 June 2026
Author(s): Mohamad Amer Nashtar, Mohammed Salemdawod, Haris Sehovic, Gizem Garipoglu, Betül Ödemis, Asterios Tzalavras, Martin Steinmetz, Ali Canbay, Mustafa Özçürümez, Varnavas Varnavas, Polykarpos Christos Patsalis, Antonios Katsounas

Patients with heart failure (HF) are particularly vulnerable to systemic infection; however, the combined impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, viral... more

Neutrophil-to-lymphocyte ratio: A disease severity biomarker in stable chronic obstructive pulmonary disease?

23 June 2026
Author(s): Marco Vanetti, Dina Visca, Francesco Ardesi, Martina Zappa, Sara Pessano, Patrizia Pignatti, Leonardo M Fabbri, Antonio Spanevello

The neutrophil-to-lymphocyte ratio (NLR) is a biomarker of systemic inflammation that has been investigated in different chronic diseases. However, its role as biomarker of severity in patients with... more

Unlocking the benefits of allopurinol: the role of timely initiation and adherence in cardiovascular and renal outcomes in hyperuricemia

20 June 2026
Author(s): András Inotai, Dávid Nagy, Gábor Kovács, Sándor Kovács, Tamás Dóczi, Balázs Nagy, Valerie Tikhonoff, Luca Degli Esposti, Zoltán Kaló, Claudio Borghi

Hyperuricemia (HU) is a prevalent chronic metabolic condition characterized by elevated serum uric acid (SUA) levels [1]. The accumulation of monosodium urate crystals in joint and extra-articular... more

Vitamin D at hospital admission as an independent predictor of outcome of sepsis patients: Results of a secondary analysis from a “Need-Speed” trial prospective cohort

19 June 2026
Author(s): Pier Paolo Sainaghi, Manuela Rizzi, Stelvio Tonello, Federica Vincenzi, Marco Primatesta, Umberto Dianzani, Roberta Rolla, Paolo Amedeo Tillio, Mario Pirisi, Enrico Lupia, Francesco Franceschi, Salvatore Di Somma, Maria Lorenza Muiesan, Gianni Biolo, Gian Carlo Avanzi, Luigi Castello, Delivida-NeedSpeed Study Group

Sepsis is currently defined as a life-threatening organ dysfunction caused by a dysregulated host response to an infection, according to the Sepsis-3 consensus [1].

Diagnostic and therapeutic inertia for LDL cholesterol management of consecutively verified patients with acute myocardial infarction

19 June 2026
Author(s): Felice Gragnano, Chiara Artana, Greta Carrara, Alice Sacco, Claudio Montalto, Marco Mennuni, Marco Zuin, Fabrizio D’Ascenzo, Fabrizio Del Nevo, Vincenzo De Sio, Leonardo De Luca, Giulia Spoto, Giuseppe Musumeci, Fabrizio Oliva, Gaetano Maria De Ferrari, Daniele Grosseto, Paolo Calabrò, Giuseppe Patti, Gianluca Campo, Sergio Leonardi, on behalf of the ATBV Quality Matters Investigators

The effective management of low-density lipoprotein cholesterol (LDL-C) after acute myocardial infarction (AMI) is a cornerstone of secondary prevention in contemporary cardiovascular care [1–5].... more

Eosinophil-linked pulmonary circulation in EGPA Improves under anti-IL-5/R therapy: A longitudinal study

19 June 2026
Author(s): Palma Carlucci, Marialuisa Sveva Marozzi, Francesco Corvasce, Silvia Noviello, Federico Spataro, Vanessa Desantis, Monica Montagnani, Roberto Ria, Sebastiano Cicco, Angelo Vacca

Eosinophilic Granulomatosis with Polyangiitis (EGPA) is a rare, multisystemic vasculitis that primarily affects small to medium-sized blood vessels. It is characterized by a well-defined triad of... more

Depressive symptoms in older patients undergoing electrical cardioversion of persistent atrial fibrillation. A possible association with clinical complexity, physical performance and inflammation

18 June 2026
Author(s): Stefano Fumagalli, Michele Biagioli, Marta Niccolini, Arianna Tariello, Elisa Berni, Domenico Davino, Veronica De Angelis, Emanuele Santamaria, Alessandro Mengozzi, Claudia Di Serio, Giulia Spanalatte, Djullye Miduri Da Silva Nakano, Camilla Cagnoni, Denise De Grazia, Igor Diemberger, Agostino Virdis

Atrial fibrillation is the most frequently sustained arrhythmia diagnosed in older individuals. In 15 years, the prevalence of AF greatly increased in subjects ≥85 years approaching 40% [1]. The... more

Asymptomatic atrial fibrillation in patients treated with BTK inhibitors in hematologic malignancies: a systematic review and metanalysis

16 June 2026
Author(s): Giuseppe Boriani, Jacopo Francesco Imberti, Annachiara Valenti, Marco Vitolo, Teresa Lopez-Fernandez, Davide Antonio Mei

Atrial fibrillation (AF) is a frequent complication of Bruton’s tyrosine kinase inhibitor (BTKi) therapy, yet the proportion of asymptomatic AF events in this setting remains poorly defined.

Fibroblast growth factor 23 and mortality, heart failure and cardiovascular events across the chronic kidney disease spectrum - A systematic review and meta-analysis

13 June 2026
Author(s): Daniele Vetrano, Antonio De Pascalis, Alessandro Tomassetti, Giorgia Comai, Miriam Di Nunzio, Simona Barbuto, Gianfranco Sinagra, Gaetano La Manna, Giuseppe Cianciolo

Chronic kidney disease (CKD) is a highly prevalent condition worldwide and is associated with a substantial cardiovascular burden and premature mortality [1,2]. The risk of cardiovascular events and... more

How many blood eosinophil measurements are needed to identify COPD patients eligible for biologic therapy? A multi-source decision analysis simulation

12 June 2026
Author(s): Pier-Valerio Mari, Angelo Coppola, Simone Ielo, Raffaele Scala, Eugenio de Corso, Veronica Ojetti, Alberto Ricci, Stefano Baglioni, Lorenzo Carriera

Biologic therapies for eosinophilic COPD require a blood eosinophil count (BEC) ≥300 cells/µL for eligibility. Landmark trials used a single screening measurement, yet BEC exhibits substantial within... more

Window of opportunity with abatacept in Rheumatoid arthritis-associated interstitial lung disease

11 June 2026
Author(s): Ana Serrano-Combarro, Belén Atienza-Mateo, Adrián Martín-Gutierrez, Libe Ibarrola Paino, Ivette Casafont-Solé, Jesús Loarce-Martos, Juan María Blanco-Madrigal, Rafaela Ortega-Castro, Natalia Mena-Vázquez, Carlos Fernández-Díaz, Javier Loricera, Diego Ferrer-Pargada, Iván Ferraz-Amaro, Santos Castañeda, Ricardo Blanco, Spanish Collaborative Group of Interstitial Lung Disease Associated with Rheumatoid Arthritis

ABA stabilised lung function, improved RA control, and reduced glucocorticoid use.Earlier initiation was associated with better DLCO preservation in adjusted analyses, suggesting a possible pulmonary... more

Cardiological hypertensive emergencies: Real word data compared to guidelines indications

9 June 2026
Author(s): Filippo Brucato, Chiara Tognola, Lorenzo De Censi, Elisa Andrian, Andrea Tacchetto, Beatrice Invernici, Sara D’alesio, Silvia Gheda, Nicolò Capsoni, Filippo Galbiati, Bombelli Michele, Cristina Giannattasio, Alessandro Maloberti

Hypertensive Emergencies (HE) are defined as a severe elevation in Blood Pressure (BP), i.e. higher than 180/120 mmHg, associated with the evidence of a new or worsening Hypertension Mediated Organ... more

Polycythemia, SGLT2 inhibitors, and associated outcomes across the cardio-kidney-metabolic spectrum: a pooled analysis of randomized trials

8 June 2026
Author(s): Pedro Marques, Francisco Vasques-Nóvoa, Mariana Pintalhão, Rui Bergantim, Luís Mendonça, João Sérgio Neves, Fernando Friões, Abhinav Sharma, Gerassimos Filipatos, Javed Butler, Stefan Anker, Faiez Zannad, Milton Packer, João Pedro Ferreira

Sodium-glucose co-transporter 2 inhibitors (SGLT2i) increase hemoglobin and hematocrit, effects that have emerged as key statistical mediators of the cardiorenal benefits observed with SGLT2i... more

Recurrent t(9;12) translocation disrupting ACVRL1 intron 9 causes hereditary haemorrhagic telangiectasia missed by standard exome sequencing in four unrelated families

6 June 2026
Author(s): Anna Esteve-Garcia, Irene Madrigal, Cinthia Aguilera, Cristina Sau, Virginia Aquino, Joan Albert Barberà, Aurora Sánchez, Beatriz Morte, Laia Rodríguez-Revenga, María Isabel Alvarez-Mora, Jesus Ribas, Raquel Torres-Iglesias, Alejandro Portillo Medina, Antoni Riera-Mestre, Ariadna Padró-Miquel

Hereditary haemorrhagic telangiectasia (HHT) (MIM #187300, ORPHA:774), also known as Rendu-Osler-Weber disease, is a rare autosomal dominant vascular disorder and the second most common inherited... more

Phase III maintenance telerehabilitation in elderly patients with chronic heart failure and type 2 diabetes (TELEMECHRON study)

6 June 2026
Author(s): Simonetta Scalvini, Veronica Donati, Emanuela Zanelli, Vittorio Giudici, Luigina Viscardi, Salvatore D'Isa, Roberto Trevisan, Palmira Bernocchi

Heart failure (HF) and type 2 diabetes (T2DM) are significant public health concerns. This study evaluated a 6-month home-based telemedicine program for older patients with combined HF and T2DM. The... more

Sex and 30-day mortality in elderly critically Ill adults: A frailty-adjusted multinational analysis with frequentist and bayesian estimates

5 June 2026
Author(s): Daniel Dankl, Raphael Romano Bruno, Michael Beil, Hans Flaatten, Malte Kelm, Sviri Sigal, Wojciech Szczeklik, Muhammed Elhadi, Michael Joannidis, Andreas Koköfer, Barbara Schreiber, Franz Singhartinger, Sandra Oeyen, Brian Marsh, Rui Moreno, Susannah Leaver, Dylan W De Lange, Bertrand Guidet, Ariane Boumendil, Christian Jung, Bernhard Wernly

Evidence on sex-related mortality differences in critically ill older adults is inconsistent, and frailty is rarely incorporated despite its major prognostic relevance in geriatric intensive care.

Prevalence and impact of psychiatric and neurocognitive comorbidities on pulmonary rehabilitation outcomes

5 June 2026
Author(s): Michele Vitacca, Adriana Olivares, Roberta Borri, Valeria Torlaschi, Lidia Gazzi, Daniel Michael Portolani, Cinzia Lastoria, Simona Aggiato, Claudio Candia, Mauro Maniscalco, Giuseppina Cassetti, Martina Vigorè, Simona Merla, Gundi Steinhilber, Pasquale Moretta

Chronic respiratory diseases are associated with psychiatric/neurocognitive comorbidities; prevalence, clinical impact and responsiveness to in-patient pulmonary rehabilitation (PR) remain poorly... more

Pre-admission and in-hospital embolisms have a different prognostic significance in infective endocarditis

4 June 2026
Author(s): María de Miguel-Álava, Javier López, Isidre Vilacosta, Carmen Olmos, Carmen Sáez, Gonzalo Cabezón, Daniel Gómez Ramírez, Patricia Landín, Victoria Gutiérrez Gómez-lus, Adrián Lozano, Andrea Oña, Itziar Gómez-Salvador, J.Alberto San Román

To describe the clinical profile of a large cohort of patients with left-sided IE (LSIE) and embolic events (EE); to explore differences between those who present with an embolism at admission (EEa)... more

Innovative co-management between Neuro-ICU and Neurorehabilitation Unit in patients with severe acquired brain injury: enhancing clinical care pathways

30 May 2026
Author(s): Camilla Grifoni, Luca Bucciardini

Severe acquired brain injury (sABI) is a major challenge in post-acute care, affecting disability, quality of life, and healthcare resources. Traditional sequential care from acute units to... more

Anti-Ro/SSA and rheumatoid factor antibodies are associated with more severe lung involvement in patients with systemic sclerosis: a study from the EUSTAR database

26 May 2026
Author(s): Blaž Burja, Marouane Boubaya, Cosimo Bruni, Lisa Christ, Lidia P. Ananyeva, Fabiola Atzeni, Christina Bergmann, Patricia E. Carreira, Jeska De Vries-Bouwstra, Nicoletta Del Papa, Antonella Marcoccia, Okada Masado, Gabriela Riemekasten, Edoardo Rosato, Tim Schmeiser, Marco Sprecher, Anna-Maria Hoffmann-Vold, Florian Kollert, Sabina Guler, Oliver Distler, Muriel Elhai, EUSTAR collaborators

In the large EUSTAR cohort, anti-Ro/SSA antibodies are detected in 15% of SSc patients and represent an independent risk factor for the presence and severity of ILD, particularly for cases with anti-... more

Development and external validation of an international score to predict cancer 1 year after venous thromboembolism

25 May 2026
Author(s): Luis Jara-Palomares, Behnood Bikdeli, David Jiménez, Alfonso Muriel, Yugo Yamashita, Marc Carrier, Isabelle Mahé, Farès Moustafa, José Luis Fernández-Reyes, Juan Gorostidi-Pérez, María de la Roca Toda, Peter Verhamme, Maria Barca-Hernando, Melisa González-Acosta, Henry Antonio Andrade-Ruiz, Manuel Monreal, the RIETE Investigators

Routine cancer screening is not recommended after venous thromboembolism (VTE), but improved risk stratification may support tailored strategies.

Epicardial fat enhances prediction of exercise-induced hypertension and ventricular arrhythmias in asymptomatic normotensive individuals

23 May 2026
Author(s): Klara Komici, Giuseppe Rengo, Grazia Daniela Femminella, Raffaela Pagliaro, Maria Luisa D'Onghia, Laura Fasciano, Gaetano Santulli, Pasquale Mone, Andrea Bianco, Germano Guerra

Exercise stress testing is commonly used to evaluate the cardiovascular response to exercise and to identify coronary artery abnormalities and arrhythmias. The normal physiological response to... more

Exercise pulmonary hypertension in asymptomatic patients with HIV infection Insights from the RIGHT-NET registry

18 May 2026
Author(s): R Madonna, AM Marra, F Biondi, A Carbone, E Carluccio, V Codullo, M D’Alto, A D’Agostino, M De Luca, AM Esposito, F Ferrara, S Ghio, M Franzese, M Zanfardino, R Naeije, R De Caterina, E Bossone

Asymptomatic patients with Human Immunodeficiency Virus (HIV) infection may remain at increased risk for pulmonary vascular disease. We therefore explored the pulmonary circulation in these patients... more

Pulmonary artery dilation in pulmonary arterial hypertension: haemodynamic determinants and association with sudden death

15 May 2026
Author(s): Fabio Dardi, Federico Donato, Francesco Cennerazzo, Fabio Niro, Alberto Ballerini, Daniele Guarino, Vincenzo Russo, Riccardo Bertozzi, Elena Nardi, Alessandra Manes, Massimiliano Palazzini, Luigi Lovato, Nazzareno Galiè

Pulmonary arterial hypertension (PAH) is a progressive disease characterized by increased pulmonary vascular resistance and pressure, leading to right ventricular failure and reduced survival.... more

Sex-related disparities in sepsis in western Europe: A systematic review and meta-analysis

11 May 2026
Author(s): Hagar L. Mowafy, Nicolas Garin, Antonios Katsounas, Pere Castellvi, Jordi Rello, On behalf of ESGIE/ESGCIP study group investigators

Sepsis is a potentially fatal systemic disease characterized by dysregulated immune response to infection [1]. Despite significant improvements in early detection and management, sepsis continues to... more

Discharge medical treatment implementation and predictors of a successful decongestion in patients with acute heart failure: first data from the BRING-UP 3 Heart Failure Study

8 May 2026
Author(s): BRING-UP 3 Heart Failure Investigators

Current discharge management of acute heart failure patients and clinical predictors of successful decongestion in a large Italian network of cardiology sites.AF, atrial fibrillation; BMI, body mass... more

Infectious complications of ANCA-associated vasculitis: Description and associated outcome

8 May 2026
Author(s): Jeanne Morin, Pierre-André Jarrot, Justine Solignac, Flora Lefevre, Philippe Brunet, Gilles Kaplanski, Stéphane Burtey, Laurent Daniel, Julia Torrents, Julien Faraut, Noémie Jourde-Chiche, Mickaël Bobot

ANCA-associated vasculitis (AAV) are a systemic autoimmune disease that primarily affect small vessels, according to the Chapel Hill classification [1] and cause necrotizing vasculitis and result... more

Early vasopressin administration in septic shock: A systematic review, meta-analysis, and multicenter retrospective observational study

7 May 2026
Author(s): Chiwon Ahn, Gun Tak Lee, Jae Hwan Kim, Sejoong Ahn, Sung Yeon Hwang, Sang-Min Kim, Won Young Kim, Sung-Joon Park, Sung-Hyuk Choi, Woon Yong Kwon, Taeyoung Kong, Sung Phil Chung, Byuk Sung Ko, Kyung Hun Yoo, Tae Ho Lim, Tae Gun Shin, Kyuseok Kim, Korean Shock Society

To determine the optimal timing for initiating vasopressin in septic shock.

Hypertension and blood pressure profiles in patients with acute intermittent porphyria: a prospective case-control study

7 May 2026
Author(s): Krzysztof Jaworski, Robert Wasilewski, Jerzy Windyga, Ilona Kowalik, Hanna Szwed, Agnieszka Lipniacka, Magdalena Niedolistek, Joanna Was, Andrzej Januszewicz, Reinhold Kreutz, Franz Messerli, Rafal Dabrowski

Acute intermittent porphyria (AIP), a rare disorder of heme biosynthesis, may manifest with neurovisceral crises affecting autonomic regulation. This study aimed to assess blood pressure (BP) pattern... more

Relationship between T90 and systemic hypertension in patients with obstructive sleep apnea: Data from the European sleep apnea database

4 May 2026
Author(s): MS Tasbakan, S Svedmyr, J Bergqvist, H Hein, S Mihaicuta, Z Dogas, G Trakada, F Fanfulla, P Joppa, D Testelmans, O Ludka, M Drummond, S Matthes, H Gouveris, R Staats, OK Basoglu, ESADA Study Group

Obstructive sleep apnoea (OSA) is a sleep disorder characterized by a partial or complete cessation of upper airway during sleep. It is estimated that approximately one billion individuals between... more

Specialist or generalist management of emergency medical admissions - immediate and long-term outcomes

2 May 2026
Author(s): Richard Conway, Declan Byrne, Deirdre O’Riordan, Bernard Silke

To study whether the admission of unselected emergency medical patients, under either a Consultant with General Medicine (GIM) or Specialist accreditation, influenced either short or longer-term all-... more

Hospital-to-community care pathways for patients with heart failure, an inter-society consensus document

1 May 2026
Author(s): Mario Mallardo, Pasquale Perrone Filardi, Claudio Micheletto, Nicola Montano, Andrea Spampinato, Maurizio Volterrani, Giovanni Battista Zito, Sergio Agosti, Enrico Avogadri, Christian Basile, Michele Gabriele, Alberto M. Marra, Anna Vittoria Mattioli, Alex Micanti, Savina Nodari, Ugo Oliviero, Stefania Paolillo, Gennaro Ratti, Antonio Ruvolo, Andrea Salzano, Regina Sorrentino, Antonio Cittadini

Heart failure (HF), defined as the inability of the heart to meet the metabolic requirements of peripheral tissues, or to do so only at the expense of elevated ventricular filling pressures,... more

Effects of urine uromodulin levels on the association between sodium intake and ambulatory blood pressure in individuals with chronic kidney disease

25 April 2026
Author(s): Artemios G. Karagiannidis, Amalia Baroutidou, Marieta Theodorakopoulou, Eleni Karkamani, Sofia Manti, Zoi Afkou, Eleni Vagdatli, Danai Faitatzidou, Panagiotis Giamalis, Christodoulos Papadopoulos, Pantelis Sarafidis

In CKD, hypertension is often accompanied by sodium sensitivity. Uromodulin promotes sodium sensitivity by activating tubular sodium transporters (NKCC2, NCC). In the general population, individuals... more

Prognostic impact of percutaneous coronary intervention in acute coronary syndrome vs. elective settings in heart transplant recipients

23 April 2026
Author(s): Luisa Elbinger, Tobias Schupp, Michael Behnes, Ibrahim Akin, Angelika Costard-Jäckle, Kambis Mashayekhi, Tanja K. Rudolph, Jan Gummert, Rene Schramm, Volker Rudolph, Mohamed Ayoub

Cardiac allograft vasculopathy (CAV) affects >50% of patients following heart transplantation (HTX) within ten years and is one of the main reasons for late graft failure. The study aimed to... more

Fatty acid binding protein 4, resistin, diastolic dysfunction, and cardiovascular risk in patients with rheumatoid arthritis

22 April 2026
Author(s): Mariusz Ciołkiewicz, Anna Kuryliszyn-Moskal, Ewa Jabłońska, Wioletta Ratajczak-Wrona, Agnieszka Dakowicz, Piotr A. Klimiuk

Rheumatoid arthritis is a chronic autoimmune disease associated with CV system involvement [1]. Cardiovascular mortality and incidence of major adverse cardiovascular events (MACE) are increased by... more

Prevalence of asymptomatic bacteriuria in high-risk hematological patients and its association with bacteremia: A prospective observational study on the need for antibiotic treatment

23 March 2026
Author(s): C. Tolosa-Ridao, T. Villalobos, L. Gómez, L. Boix-Palop, M. Xercavins, A. Sangil, M. Canet, A. Mesa, M. López, A. Muntañola, F. Vall-llovera, JM Martí, M. Julià, R. Santiago, G. Bustamante, E. Viladot, B. Dietl, A. Jaén, M. Rodríguez-Carballeira, P. Pérez, E. Calbo

Antibiotic treatment for asymptomatic bacteriuria (AB) is not recommended in the general population, and its significance in oncohematological patients remains unclear.

Practice Guidelines

Identification and management of sarcopenia in patients with multimorbidity: An EFIM critically appraised and adapted guideline

13 August 2026
Author(s): M. Bernabeu-Wittel, I. Marín-León, C. Angermann, P. Cubo-Romano, Z. Cvetković, A. Dima, M. Fissah, J.A. García-García, S. García-Rubio, E. Kravvariti, A. Kurrle, O. Lidove, Z. Lys, O. Para, L. Santos, A. Tuttolomondo, J. Václavík, J. Voicehovska, D. Nieto-Martín

Sarcopenia is highly prevalent among adults with multimorbidity and contributes substantially to frailty, disability, prolonged hospitalization, and mortality. International guidelines offer robust... more

Review Article

Microvascular and macrovascular complications of diabetes in people with HIV

31 August 2026
Author(s): Maria Mazzitelli, Marco Zuin

Diabetes mellitus (DM) is increasingly prevalent in people with HIV, with reported prevalence estimates generally ranging from 5% to 15% across contemporary cohorts. It represents a major contributor... more

Personalizing cardiovascular prevention in chronic kidney disease: an operational framework for risk-treatment mapping

11 August 2026
Author(s): Carmine Zoccali, Csaba P Kovesdy, Francesca Mallamaci, Navdeep Tangri, Vianda Stel, Nisha Bansal, Peter Stenvinkel, Kitty Jager

Patients with chronic kidney disease (CKD) bear a disproportionate burden of cardiovascular (CV) morbidity and mortality, yet preventive strategies in clinical practice remain remarkably conservative... more

Sex and gender specific considerations on frailty: what have we learned?

11 August 2026
Author(s): Marzia Miglionico, Valentina Manzini, Giovanna Valentina Florelli, Giulio Francesco Romiti, Laura Bagnara, Stefania Basili, Marco Proietti, Valeria Raparelli

Aging entails a progressive impairment of functions and, ultimately, leads to increased susceptibility to disability, morbidity, and mortality. Around 85% of people aged more than 75 years suffer... more

Particle engineering, aerosol physics, and pulmonary deposition of single-inhaler triple ICS/LABA/LAMA therapies in obstructive airway diseases

1 August 2026
Author(s): Claudio Sorino, Johann Christian Virchow, Antonio Spanevello, Agata Buscemi, Fulvio Braido, Nicola Scichilone

Search Strategy

Sugar and artificial sweeteners and risk of cardiovascular disease

30 July 2026
Author(s): Antonis A. Manolis, Theodora A. Manolis, Apostolos Vouliotis, Antonis S. Manolis

Humans have an innate preference for sweetness; in this regard, dietary sugar consumption patterns are established early in life. Although moderate consumption of naturally occurring sugars from... more

Acute cardio-renal and Reno-Cardiac syndromes in critical care

29 July 2026
Author(s): Alessandro Girombelli, Yaroslava Longhitano, Francesco Vetrone, Roberto Vicinanza, Christian Zanza, “Cardiorenal Critical Care Coalition”

Cardiorenal syndrome (CRS) encompasses a spectrum of disorders in which acute or chronic dysfunction of the heart or kidneys are the key drivers of injury. CRS types 1 and 3 are the subtypes most... more

Alcohol withdrawal syndrome in hospitalized patients: a practical review

25 July 2026
Author(s): Fabio Caputo, Lisa Lungaro, Anna Costanzini, Roberto De Giorgio, Giovanni Addolorato

Alcohol withdrawal syndrome (AWS) develops in patients with alcohol use disorder (AUD) and physical dependence after abrupt cessation or substantial reduction of sustained heavy alcohol use. It is... more

Cardiovascular complications of antineoplastic treatment in prostate cancer patients and compensatory strategies for clinical management

1 July 2026
Author(s): Nikolaos Tsiamis, Fotios Toulgaridis, Eleni Stefanou, Christos Tountas, Georgios Tsitsinakis, Evangelos Ballas, Ioannis Maurogenis, Anastasia Kitsiou, Christo Kole

Prostate cancer (PCa) represents one of the most prevalent malignancies affecting men worldwide and constitutes a major public health challenge. According to the most recent GLOBOCAN estimates,... more

Testosterone therapy in chronic kidney disease patients: an underutilized resource

29 June 2026
Author(s): Sandro La Vignera, Rosita A. Condorelli

Testosterone deficiency is highly prevalent in men with chronic kidney disease (CKD), affecting 30–70% of patients depending on disease stage and diagnostic criteria. Despite its frequency and... more

Understanding the Barriers to Translating Artificial Intelligence into the Clinical Laboratory

27 June 2026
Author(s): Michael Neale, Cynthia Wong, Daniel Kreuter, Joseph Taylor, Suthesh Sivapalaratnam

Artificial intelligence (AI) is having a transformational impact on society, yet its adoption in laboratory medicine has proceeded notably slower than in many other industries and even different... more

From technology adoption to noise reduction: Behavioral and psychological dimensions of clinical artificial intelligence deployment

19 June 2026
Author(s): Daniel Ostrovsky, Uriel Haran, Victor Novack

For more than five decades, patients with the same condition have received markedly different care depending on which clinician they happen to see. This unwarranted clinical variation has been... more

Retinal microcirculation as a window to coronary artery disease

17 June 2026
Author(s): Weronika Kowalczyk, Mikołaj Basza, Joanna Przybek-Skrzypecka, Łukasz Kołtowski, Jacek Szaflik, Justyna Izdebska

Coronary artery disease includes obstructive epicardial stenosis and ischemia with non-obstructive coronary arteries driven by microvascular dysfunction. Population screening is limited by the... more

Healthcare sustainability and the planetary crisis: A solution orientation

13 June 2026
Author(s): Elizabeth Cerceo

The climate crisis is an escalating public health emergency that demands urgent, systemic action from the healthcare sector. This article presents a solution-oriented framework for integrating... more

Linking the exposome to frailty: pathways, mechanisms, clinical implications, and prevention

11 June 2026
Author(s): Mustafa Guldan, Ermeena Shah, Rama Al-Shiab, Lasin Ozbek, Adrian Covic, Mehmet Kanbay

Frailty is a state of heightened vulnerability arising from multisystem decline, in which minor stressors can precipitate disproportionate deterioration in function and health. It predicts falls,... more

Artificial intelligence in cardiovascular care for internal medicine: from promising algorithms to useful clinical services

29 May 2026
Author(s): Louis-Marie Desroche, Antonin Trimaille, Benoît Lequeux, Nicolas Homehr, Nicolas Girerd

Cardiovascular disease is a core part of internal medicine, where clinicians manage patients with multimorbidity, polypharmacy, repeated transitions of care, and a high burden of fragmented... more

Device-based therapies for cardiorenal syndrome: A comprehensive, mechanism-driven framework for next-generation decongestion

23 May 2026
Author(s): Juliana Giorgi, Salomon Chamay, Caroline O. Fischer-Bacca, Mrunalini Dandamudi, Larissa Araújo de Lucena, Deivyd Cavalcante, Miguel A. Samiego, John Cedric Mojica, Pedro Gomes Batista, Alejandro Barbagelata, Robert J. Mentz, Marat Fudim

Cardiorenal dysfunction is a major contributor to morbidity, rehospitalization, and mortality in advanced heart failure (HF) and cardiogenic shock. Traditional decongestive approaches—loop diuretics... more

Organization and delivery of home-based care for chronic obstructive pulmonary disease patients receiving long-term home non-invasive ventilation: a systematic review

13 April 2026
Author(s): Claudia Crimi, Simon Oczkowski, Annalisa Carlucci, Jean-Louis Pépin, Juliane Hafermann, Anya Lissina, Rhodri Saunders, Sarah Alami, Scott Gibson

The delivery of LTHNIV remains heterogeneous, even within countries. This variability in care organization and reporting mandates establishing harmonized, patient-centred pathways that integrate... more

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness